Mainz Biomed BV (NASDAQ:MYNZ) — Stock Price
Mainz Biomed BV (NASDAQ:MYNZ) is currently trading at $0.76 USD, down 10.15% today. Over the past 52 weeks, shares have ranged between $0.59 and $1.80. This page tracks Mainz Biomed BV's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MYNZ company net worth.
Mainz Biomed BV (MYNZ) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Mainz Biomed BV's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Mainz Biomed BV Income Statement — Revenue, Profit & Earnings by Year
Mainz Biomed BV's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $537.08K | $893.99K | $895.48K | $529.88K | $577.35K |
| Cost of Revenue | $763.01K | $319.11K | $385.82K | $347.73K | $399.73K |
| Gross Profit | $-225.93K | $574.88K | $509.66K | $182.15K | $177.62K |
| Research & Development | $4.91 Million | $5.84 Million | $9.59 Million | $3.66 Million | $466.69K |
| SG&A | $5.11 Million | $8.08 Million | $13.42 Million | $17.83 Million | $8.45 Million |
| Total Operating Expenses | $13.27 Million | $19.27 Million | $27.15 Million | $26.36 Million | $9.56 Million |
| Operating Income | $-13.50 Million | $-18.70 Million | $-26.64 Million | $-26.44 Million | $-9.72 Million |
| EBITDA | $-12.88 Million | $-19.56 Million | $-25.01 Million | $-25.72 Million | $-11.28 Million |
| EBIT | $-13.50 Million | $-20.58 Million | $-26.05 Million | $-26.18 Million | $-11.35 Million |
| Interest Expense | $373.46K | $1.08 Million | $809.58K | $289.32K | $339.17K |
| Income Before Tax | $-16.21 Million | $-21.65 Million | $-26.30 Million | $-26.39 Million | $-11.70 Million |
| Income Tax Expense | — | — | $1.92 Million | $65.39K | $377.12K |
| Net Income | $-16.21 Million | $-21.65 Million | $-26.30 Million | $-26.45 Million | $-11.69 Million |
Mainz Biomed BV Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Mainz Biomed BV's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $5.33 Million | $13.24 Million | $15.41 Million | $20.24 Million | $10.04 Million |
| Total Current Assets | $1.84 Million | $7.84 Million | $8.98 Million | $18.38 Million | $9.61 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $110.89K | $213.75K | $354.51K | $259.14K | $17.76K |
| Inventory | $216.89K | $372.87K | $613.64K | $175.47K | $-863.14 Million |
| Property, Plant & Equipment | — | — | — | — | $431.59K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $4.69 Million | $7.19 Million | $12.16 Million | $6.14 Million | $3.68 Million |
| Total Current Liabilities | $3.69 Million | $5.95 Million | $9.24 Million | $4.24 Million | $1.35 Million |
| Long-term Debt | — | — | $1.03 Million | $943.21K | $1.94 Million |
| Net Debt | $1.68 Million | $-2.96 Million | $349.86K | $-13.91 Million | $-6.15 Million |
| Total Stockholder Equity | $641.60K | $6.05 Million | $3.25 Million | $14.10 Million | $6.36 Million |
| Retained Earnings | $-104.90 Million | $-90.98 Million | $-69.33 Million | $-43.03 Million | $-16.64 Million |
Mainz Biomed BV Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Mainz Biomed BV generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-10.98 Million | $-17.09 Million | $-21.94 Million | $-14.77 Million | $-3.22 Million |
| Capital Expenditures | $1.22K | $254.95K | $1.90 Million | $658.48K | $16.70K |
| Free Cash Flow | $-10.98 Million | $-17.34 Million | $-23.84 Million | $-15.43 Million | $-3.24 Million |
| Investing Cash Flow | $-1.03 Million | $-198.82K | $-1.90 Million | $-658.48K | $1.20 Million |
| Financing Cash Flow | $6.76 Million | $16.60 Million | $14.23 Million | $23.94 Million | $10.61 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $1.20 Million | $1.14 Million | $4.01 Million | $9.82 Million | $6.43 Million |
| Depreciation | $615.72K | $1.02 Million | $866.41K | $379.80K | $69.93K |
| Change in Cash | $-5.35 Million | $-835.25K | $-10.07 Million | $8.41 Million | $8.60 Million |
Mainz Biomed BV Earnings History — EPS Actual vs. Analyst Estimates
Track Mainz Biomed BV's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 07, 2026 | 0.00 | -2.00 | +100.00% |
| Nov 28, 2025 | 0.00 | -2.00 | +100.00% |
| Sep 03, 2025 | -2.65 | -2.40 | -10.42% |
| May 30, 2025 | -7.71 | -2.80 | -175.36% |
| Mar 31, 2025 | -7.71 | -6.40 | -20.47% |
| Oct 21, 2024 | -19.60 | -0.15 | -12966.67% |
| Jun 30, 2024 | — | -9.00 | — |
| Apr 09, 2024 | -0.24 | -0.32 | +25.00% |